125 related articles for article (PubMed ID: 7897345)
1. Identification of human papillomavirus seroconversions.
Wikström A; van Doornum GJ; Quint WG; Schiller JT; Dillner J
J Gen Virol; 1995 Mar; 76 ( Pt 3)():529-39. PubMed ID: 7897345
[TBL] [Abstract][Full Text] [Related]
2. Clinical and serological manifestations of genital human papillomavirus infection.
Wikström A
Acta Derm Venereol Suppl (Stockh); 1995; 193():1-85. PubMed ID: 8721519
[TBL] [Abstract][Full Text] [Related]
3. Prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infection.
Wikström A; van Doornum GJ; Kirnbauer R; Quint WG; Dillner J
J Med Virol; 1995 Aug; 46(4):368-74. PubMed ID: 7595415
[TBL] [Abstract][Full Text] [Related]
4. Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata.
Wikström A; Eklund C; Von Krogh G; Lidbrink P; Dillner J
J Clin Microbiol; 1992 Jul; 30(7):1795-800. PubMed ID: 1378454
[TBL] [Abstract][Full Text] [Related]
5. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection.
Carter JJ; Koutsky LA; Hughes JP; Lee SK; Kuypers J; Kiviat N; Galloway DA
J Infect Dis; 2000 Jun; 181(6):1911-9. PubMed ID: 10837170
[TBL] [Abstract][Full Text] [Related]
6. Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study.
Van Doornum GJ; Prins M; Juffermans LH; Hooykaas C; van den Hoek JA; Coutinho RA; Quint WG
Genitourin Med; 1994 Aug; 70(4):240-6. PubMed ID: 7959707
[TBL] [Abstract][Full Text] [Related]
7. Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women.
Petter A; Heim K; Guger M; Ciresa-Kö Nig A; Christensen N; Sarcletti M; Wieland U; Pfister H; Zangerle R; Höpfl R
J Gen Virol; 2000 Mar; 81(Pt 3):701-8. PubMed ID: 10675407
[TBL] [Abstract][Full Text] [Related]
8. [Specific serologic studies with a novel authentic HPV antigen (virus-like particles) for HPV-6 antibodies in gynecologic patient samples].
Heim K; Christensen ND; Höpfl R; Wartusch B; Zeimet A; Larcher C; Ruth N; Bergant A; Pirschner G; Dierich MP
Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():25-31. PubMed ID: 8672922
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of antibody responses to defined epitopes of human papillomavirus (HPV) type 16 in relationship to genital and anorectal presence of HPV DNA.
Van Doornum GJ; Prins M; Pronk L; Coutinho RA; Dillner J
Clin Diagn Lab Immunol; 1994 Nov; 1(6):633-9. PubMed ID: 8556513
[TBL] [Abstract][Full Text] [Related]
10. Identification of seroreactive epitopes of human papillomavirus type 18 E7 protein by synthetic peptides.
Krchnák V; Pistĕk T; Vágner J; Suchánková A; Kañka J; Ritterová L; Vonka V
Acta Virol; 1993 Oct; 37(5):395-402. PubMed ID: 7514354
[TBL] [Abstract][Full Text] [Related]
11. Association of serum antibodies against defined epitopes of human papillomavirus L1, E2, and E7 antigens and of HPV DNA with incident cervical cancer.
Dillner L; Zellbi A; Avall-Lundqvist E; Heino P; Eklund C; Pettersson CA; Forslund O; Hansson BG; Grandien M; Bistoletti P
Cancer Detect Prev; 1995; 19(5):381-93. PubMed ID: 7585724
[TBL] [Abstract][Full Text] [Related]
12. Antibodies against papillomavirus antigens in cervical secretions from condyloma patients.
Dillner L; Fredriksson A; Persson E; Forslund O; Hansson BG; Dillner J
J Clin Microbiol; 1993 Feb; 31(2):192-7. PubMed ID: 8381807
[TBL] [Abstract][Full Text] [Related]
13. Seroepidemiologic studies of bovine papillomavirus infections.
Pfister H; Huchthausen B; Gross G; zur Hausen H
J Natl Cancer Inst; 1979 Jun; 62(6):1423-5. PubMed ID: 220453
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic.
Kiviat NB; Koutsky LA; Paavonen JA; Galloway DA; Critchlow CW; Beckmann AM; McDougall JK; Peterson ML; Stevens CE; Lipinski CM
J Infect Dis; 1989 Feb; 159(2):293-302. PubMed ID: 2536781
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus vaccine development.
Fife KH
Australas J Dermatol; 1998 Nov; 39 Suppl 1():S8-10. PubMed ID: 9842094
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of human papillomavirus infection and HPV DNA among male partners of Israeli women with genital premalignant and human papillomavirus lesions.
Bar-Am A; Niv J; Jaffo A; Peyser RM
Isr J Med Sci; 1995 Jun; 31(6):349-52. PubMed ID: 7607853
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of genital HPV infections and HPV serology in adolescent girls, prior to vaccination.
Mollers M; Scherpenisse M; van der Klis FR; King AJ; van Rossum TG; van Logchem EM; Feltkamp MC; Meijer CJ; Snijders PJ; Boot HJ; de Melker HE
Cancer Epidemiol; 2012 Dec; 36(6):519-24. PubMed ID: 22906483
[TBL] [Abstract][Full Text] [Related]
18. Use of human papillomavirus type 11 virions in an ELISA to detect specific antibodies in humans with condylomata acuminata.
Bonnez W; Da Rin C; Rose RC; Reichman RC
J Gen Virol; 1991 Jun; 72 ( Pt 6)():1343-7. PubMed ID: 1646276
[TBL] [Abstract][Full Text] [Related]
19. Presence of antibody reactive with synthetic peptide derived from L2 open reading frame of human papillomavirus types 6b and 11 in human sera.
Suchánková A; Ritter O; Hirsch I; Krchnák V; Kalos Z; Hamsíková E; Brichácek B; Vonka V
Acta Virol; 1990 Sep; 34(5):433-42. PubMed ID: 1705748
[TBL] [Abstract][Full Text] [Related]
20. The role of the immune system in anogenital human papillomavirus.
Frazer IH
Australas J Dermatol; 1998 Nov; 39 Suppl 1():S5-7. PubMed ID: 9842093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
